Loading

Aguarde, carregando...

Logo Câmara Municipal de Água Azul do Norte, Pa

Ventolin

Shamsuddin Akhtar, MBBS

  • Associate Professor
  • Department of Anesthesiology
  • Yale University School of Medicine
  • New Haven, Connecticut

Although this occasionally can be achieved in the emergency department setting chronic asthma definition 100 mcg ventolin otc, abdominal straining by the infant may make this procedure difficult asthma symptoms baby coughing ventolin 100 mcg mastercard, and treatment under general anesthesia often is preferable asthma symptoms not improving generic 100 mcg ventolin with visa. Injection of radiographic contrast material into the ureterocele can be helpful in identifying the relevant anatomy asthma treatment chiropractic ventolin 100 mcg buy on line. Ectopic Ureteral Insertion In females an ectopic ureter may enter distal to the urethral sphincter asthmatic bronchitis coding order ventolin 100 mcg with amex. Ectopic ureters to the vestibule are typically associated with diurnal incontinence in the presence of normal voiding habits. However, single-system ectopic ureters also may manifest in this fashion and on occasion can be associated with apparent complete absence of the kidney. Simple aspiration of the vagina without a definite drainage procedure should be discouraged because incompletely evacuated material may be prone to ascending bacterial growth. In pubertal girls, general anesthesia with excision of excess hymenal tissue may be indicated. The associated finding of a hematoma, abrasion, or laceration in combination with hymenal transection should raise the possibility of this diagnosis. Proper examination under anesthesia and forensic swabbing of affected areas should be undertaken with the use of a standardized protocol. DisordersoftheVagina Imperforate Hymen and Hymenal Skin Tags Hymenal skin tags are virtually a normal finding and are rarely symptomatic. Congenital abnormalities of the hymen are not uncommon and range from an imperforate hymen to one with numerous small microperforations. Imperforate hymen is probably the most common congenital obstructive anomaly of the female reproductive tract. The diagnosis is most frequently made at birth by noting the presence of a bulge along the posterior aspect of the introitus, which represents retained fluid within the vagina, or by palpation of a suprapubic mass from a distended vagina. The buildup of retained vaginal secretions in the neonatal period, which imparts a whitish appearance to the bulging hymenal membrane, is caused by maternal estradiol stimulation. If the diagnosis is made after the neonatal period, the mucus often will have been reabsorbed and a bulge in the hymenal membrane may no longer be evident. On occasion, the diagnosis is not made until the adolescent period, when the patient experiences amenorrhea and possibly cyclic abdominal pain. In these circumstances, a bluish bulging hymen may be observed on genital inspection and a mass will be appreciated on rectoabdominal palpation. In newborns, repair by incision of the hymenal tissue at the bedside is performed in the transverse direc- Abnormalities of Vertical Fusion Transverse Vaginal Septum. The estimated incidence of transverse vaginal septum is 1 in 70,000 females (Banerjee and Laufer, 1998). A complete transverse vaginal septum may be located at various levels in the vagina, but there is a higher frequency in the middle and upper third of the vagina. In one large series the distribution was 46% in the upper vagina, 40% in the middle vagina, and 14% in the lower vagina. The septa are usually less than 1 cm thick and frequently have a small central or eccentric perforation (Suidan and Azoury, 1979). Even in cases in which a perforation is present, significant obstruction and ascending infection can occur. Failure to differentiate between these diagnoses can result in significant patient morbidity (Casey and Laufer, 1997). Several surgical treatment modalities have been developed to treat congenital transverse vaginal septa. This may allow time for dilation of the lower vaginal segment, potentially improving the ease of surgical repair. Techniques include simple incision (Brenne et al, 1965; Buttram, 1983), surgical excision of the septum followed by approximation of the corresponding portions of the transversely cut edges of the upper and lower mucosal membranes of the septum (Rock et al, 1982) and the use of Z-plasties involving vaginal mucosa (Wierrani et al, 2003). Recently we described a method that improves the safety of entering the obstructed vaginal segment and subsequently excising the septum (Keenan and Kaefer, 2010). Under ultrasound guidance a 14-guage angiocatheter is placed through the thick transverse septum. The balloon is insufflated and subsequently removed, providing a generous aperture through which the remainder of the septum can be excised. Vaginal stenosis at the site of resection is the most common complication (Joki-Erkkila and Heinonen, 2003). The primary advantage of a Z-plasty is that as the suture line contracts the incision is more likely to take on a longitudinal rather than a transverse orientation. Placement of a vaginal mold subsequent to surgery has been reported to further reduce the risk for postoperative stenosis (Bijsterveldt and Willemsen, 2009). Characteristics of molds for transverse septa are different from those used after a McIndoe vaginoplasty (see later). Whereas a solid mold may be used after a vaginoplasty skin graft (because there is no uterus), the mold used after resection of a transverse septum is ideally hollow, to allow egress of menstrual flow. Vaginal atresia occurs when the urogenital sinus fails to contribute to formation of the lower (distal) portion of the vagina. A very shallow dimple caudal to the urethral opening may be appreciated on physical examination. Palpation of a distended vagina on rectal examination may help distinguish this condition from testicular feminization or vaginal agenesis. Surgical correction consists of a transverse incision at the level of the hymenal ring. Dissection is carried out through the fibrous area of the absent lower vagina until the upper vagina is reached. As in treatment of a transverse vaginal septum, distention of the vagina with retained menstrual blood products can prove extremely beneficial in that it acts as a tissue expander. After the obstruction is drained and the vaginal mucosa is identified, a pull-through procedure can be performed to bring the distended vagina down to the introitus. The distance to bridge between the vagina and the perineal surface almost always can be successfully managed with perineal skin flaps or simple mobilization of the vagina (or both). Ramenofsky and Raffensperger (1971) described a combined abdominoperineal approach that can be of help in exposing and anastomosing the distal vagina to the perineal skin. Vaginal agenesis, which occurs at an incidence of approximately 1 in 5000 live female births, is congenital absence of the proximal portion of the vagina in an otherwise phenotypically. Although Renaldus Columbus is credited by some authors as the first to describe a case of vaginal agenesis, Mayer (1829) was one of the first to report vaginal agenesis in stillborn children (Lesavoy, 1985). In 1838, Rokitansky (1838) reported 19 adult autopsy cases of uterovaginal agenesis, including 3 with associated unilateral renal agenesis. In 1910, Küster (1910) recognized urologic associations, such as renal ectopy and agenesis, along with skeletal deformities. Hauser and Schreiner (1961) brought further attention to the frequent association of renal and skeletal anomalies in these patients and stressed the differences between patients with these findings and those with testicular feminization. This may be caused by improper induction of the sinovaginal bulbs from the neighboring uterovaginal primordium. Chronologically, the uterovaginal canal develops at a point in embryogenesis during which other critical mesodermally derived organ systems are also forming, which in part explains the many associated findings. Müllerian aplasia also has been associated with maternal deficiency of galactose-1-phosphate uridyltransferase (Cramer et al, 1996). In contrast to vaginal atresia, the hymenal fringe is usually present, along with a small vaginal pouch, because they are both derived embryologically from the urogenital sinus. This syndrome is in fact second only to gonadal dysgenesis as a cause of primary amenorrhea. A minority of patients have cyclic abdominal pain caused by retention of menstrual blood in the uterus. Inguinal hernia is less common in this disorder than in the testicular feminization syndrome (Schmid-Tannwald and Hauser, 1973). Radiographic evaluation is indicated to more fully delineate remnant müllerian structures and search for associated anomalies involving the renal and skeletal systems. In approximately 10% of patients, a normal but obstructed uterus or a rudimentary uterus with functional endometrium is present (Murray and Gambrell, 1979; Singh and Devi, 1983; Bates and Wiser, 1985). In one of the largest single series to date, Salvatore and Lodovicci (1978) reported that of 91 patients with vaginal agenesis, almost 25% lacked a uterus, 55% had a solid rudimentary uterus, and the remaining 30% had other abnormalities of this organ. In addition, they demonstrated that although the fallopian tubes were normal in 32% of cases, they were rudimentary in almost 50% and completely absent in 10%. Although occasionally cystic, the ovaries were almost always present and functional (Salvatore and Lodovicci, 1978). The atypical form (type B) is characterized by asymmetrical uterine buds or abnormally developed fallopian tubes. This distinction is important because the overwhelming majority of associated findings in other organ systems have been reported to be present with the atypical form, whereas in the typical form these findings are usually absent (Strubbe et al, 1992, 1993). The association between vaginal agenesis and developmental abnormalities of the kidney was first recognized by Rokitansky (1838). Approximately a third of patients are found to have abnormal renal findings on intravenous pyelography or ultrasound examination (Strubbe et al, 1993). Renal anomalies are present almost exclusively in patients with the atypical subtype of vaginal agenesis (type B). In the series by Strubbe and colleagues (1993), 34 of 51 patients with type B anatomy had renal anomalies, but none of the 40 patients with type A (symmetrical) anatomy demonstrated such a deformity. A meta-analysis published by Griffin and associates (1976) demonstrated that the renal anomaly consists of either unilateral renal agenesis or ectopia of one or both kidneys in 74% of those affected. The close proximity of the mesonephric and paramesonephric structures during the early phase of fetal development is thought to be the reason for this frequent association of renal anomalies. Not surprisingly, the converse is also true: the incidence of associated genital abnormalities in female patients with renal anomalies ranges between 25% and 89% (Thompson and Lynn, 1966). Associated congenital abnormalities of the skeletal system have been described in 10% to 20% of cases (Turunen, 1967; Willemsen, 1982; Strubbe et al, 1987). Congenital fusion (failure of segmentation) of the cervical vertebrae is known as the Klippel-Feil syndrome and occurs approximately once in 30,000 to 40,000 live births (Gunderson et al, 1967). An association between this abnormality of cervical somite development and vaginal agenesis was first recognized by Duncan (1977). Additional, albeit less common, skeletal abnormalities include scoliosis and abnormalities of the hands and face (Willemsen, 1982; Fisher et al, 2000). Unlike müllerian anomalies that are associated with abnormal cloacal septation, vaginal agenesis is not associated with an increased incidence of lumbosacral spinal disorders or occult spinal dysraphism (Gunderson et al, 1967). Regardless of the method used, it can be very helpful to have the patient speak with someone who has previously undergone treatment before treatment is initiated (Ingram, 1981). The nonoperative approach has greatest success when a vaginal dimple or pouch is already present (Williams et al, 1984, 1985). Gargollo and colleagues (2009) recently reported their experience with 69 females (mean 17. Success, defined as the ability to achieve sexual intercourse, vaginal acceptance of the largest dilator without discomfort, or a vaginal length of 7 cm, was achieved in 88% of patients. The authors concluded that progressive perineal dilation should be offered as first-line therapy in adolescents with congenitally absent vagina. Modifications of the Frank technique of perineal pressure have been developed that incorporate the surgical placement of tension sutures to aid in directing pressure from a Plexiglas dilator against the vaginal dimple (Vecchietti, 1979). The mold, often referred to as an "olive," has sutures attached to it that are guided in a cranial direction through the vesicorectal space into the perineal cavity and brought out through the abdominal wall (Vecchietti technique). Tension is progressively increased via the abdominal wall sutures until sufficient vaginal length has been achieved. To avoid a formal laparotomy, laparoscopic techniques have been described to assist in dissection of the tissue plane for the Vecchietti technique (Borruto, 1992; Gauwerky et al, 1992; Fedele et al, 1996, 1999; Brucker et al, 2008). In the more recent series by Fedele and colleagues (2006), all patients were found to have healthy vaginal mucosa, with the average vaginal length being almost 8 cm at 3 months. If the Frank method has been unsuccessful or is not accepted as a reasonable option by the patient or parents, creation of a functional vagina can be achieved by one of several techniques (Abbé, 1898; McIndoe and Banister, 1938; Hendren and Atala, 1994). The first landmark advance in vaginal reconstruction is attributed to Abbé in 1898. Abbé described dissecting a canal between the rectum and urethra and lining this area with split-thickness skin grafts. This method was later popularized by McIndoe, and the procedure that bears his name has gained wide acceptance in the United States (McIndoe and Banister, 1938). Preoperative preparation consists of full mechanical and antibiotic bowel preparation. A transverse incision is made at the level of the perineal dimple, and the potential space between the urethra and the rectum is carefully dissected up to the level of the peritoneal reflection. The graft and mold are then inserted into the potential space, and the labia minora are sutured around the stent to prevent extrusion during the initial healing phase (McIndoe, 1950). The Foley catheter is replaced by a suprapubic catheter, and postoperatively the patient is kept at strict bed rest for 1 full week. A high incidence of postoperative vaginal stenosis necessitates postoperative vaginal dilation (Ingram, 1981). Excellent patient satisfaction has been reported in most large series (Martinez-Mora et al, 1992; Strickland et al, 1993; Alessandrescu et al, 1996). Other options for creation of a neovagina with local tissues include the use of full-thickness skin grafts from the buttocks or full-thickness skin flaps based on the labia majora. Those who champion the use of full-thickness skin grafts report a lower incidence of graft contracture than when split-thickness graft techniques are used (Sadove and Horton, 1988). The Williams (1964) vaginoplasty involves the creation of a vaginal pouch from the labia majora. The combination of this procedure and Frank-type dilation along the vaginal axis can provide a satisfactory result. Many other surgical procedures have been developed for creation of a functional neovagina with various muscle flaps. The pelvic peritoneum and human amnion are two other donor sites that have been used to create a neovagina (Davydov, 1977; Ashworth et al, 1986; Morton and Dewhurst, 1986; Tamaya and Imai, 1991; Marquis et al, 2008). The procedure involved anastomosis of a U-shaped segment of sigmoid colon to the perineum with subsequent division of the intervening septum (Hensle and Dean, 1992).

discount ventolin 100 mcg online

She also told me that she was strictly forbidden to mention her colored letters in any way to any other people besides doctors asthma xanax buy ventolin with paypal, and was often locked up in her room and denied contact with any other people besides her immediate family asthma education materials cheap ventolin 100 mcg amex. When I last heard from her asthma nos discount 100 mcg ventolin, she was still roaming the southern United States asthma winter discount ventolin 100 mcg line, had determined never to return to her parents asthma back pain order ventolin 100 mcg otc, and had gotten a job (she would not reveal where) as an artist, she based her artwork on various things she "saw" synesthetically. This is not to say, however, that all or even most synesthetes have had severe problems with their conditions, nor that synesthesia is a drawback for everyone. Take, for example, the situation with Ian (a pseudonym), a 12-year-old synesthete I am currently assisting. Ian has colored-grapheme synesthesia, and is currently having trouble with algebra in school. Both he and his parents, as well as some of his teachers and administrators at his school, were worried that this form of synesthesia might, in itself, somehow create an insurmountable drawback for Ian in a number of academic areas. It gave them comfort to hear that not only did people use colored letters and numbers to advantage, but that Richard Feynman used his to memorize formulae that gained him a Nobel Prize (the fact that synesthete Vladimir Nabokov [figure 2. A recent subscriber to the Synesthesia List wrote, I have an intense association between colours and numbers. Three is yellow for me and five is blue so I drew a merging of blue and yellow (a nice kind of green) as my answer. However, I do not wish to convey that these types of synesthesia always present a problem for the synesthete, nor that they cannot be overcome- often in amusing and enjoyable manners. Then there is the story of a synesthete I know who replaced all of the keys on his laptop computer. Rather than displaying the graphemes, the new keys displayed only the colors which corresponded with each grapheme, creating a rainbow across the keyboard. After having done this, my friend reported that it was so much easier for him to recognize the various keys that his typing at least doubled in speed! There have been many major figures who have not kept their synesthesia hidden, and have even used their synesthesia to advantage in their work. Nikolai Rimsky-Korsakov (1844-1908) had synesthetically colored musical keys: C major G major white brownish-gold, light D major A major E major B major F major D[, major At, major E, major B^ major F major daylight, yellowish, royal clear, pink blue, sapphire, bright gloomy, dark blue with steel shine grayish-green darkish, warm grayish-violet dark, gloomy, gray-bluish darkish green, clear (color of greenery) this is according to an article in the Russian press (Yastrebtsev, 1908). Thus C was white, F-sharp black, E yellow, G red, A green, A-flat blue, D-flat violet or purple, and E-flat pink. Everything he saw produced a corresponding impression on his ear-every impression of sound was transferred and fixed as color on the retina of his eye and thence to his memory. And this he thought as natural, with as good reason as those who did not possess this faculty called him crazy or affectedly original. For this reason he only spoke of this in the strictest confidence and under a pledge of silence. Synesthete composers and musicians now living include the Hungarian Gyorgy Ligeti (born 1923). Ligeti is probably best known to the wider world for his early works, some of which were used by Stanley Kubrick for the soundtrack of 2001. Like Rimbaud [Rimbaud was most likely not a true synesthete], I feel that all letters have a colour. I do not have perfect pitch, so when I say that C minor has a rusty red-brown colour and D minor is brown this does not come from the pitch but from the letters C and D. I find, for instance, that numbers also have colours; 1 is steely grey, 2 is orange, 5 is green. At some point these associations must have got fixed, perhaps I saw the green number 5 on a stamp or on a shop sign. For most people the sound of a trumpet is probably yellow although I find it red because of its shrillness. There is also the contemporary composer Michael Torke, definitely a synesthete, reporting that one of his types is colored time units (days of the week, years, and such). Torke has composed pieces with titles such as "Ecstatic Orange" and "Bright Blue Music. In the realm of creative fiction writers, there have also been more than a few synesthetes. In his autobiography, Speak Memory (1966), Nabokov tells us of his fine case of colored hearing. Perhaps "hearing" is not quite accurate, since the color sensation seems to be produced by the very act of my orally forming a given letter while I imagine its outline. The long a of the English alphabet (and it is this alphabet I have in mind farther on unless otherwise stated) has for me the tint of weathered wood, but a French a evokes polished ebony. This black group also includes hard g (vulcanized rubber) and r (a sooty rag bag being ripped). Oatmeal n, noodle-limp 1, and the ivory-backed hand mirror of o take care of the whites. I am puzzled by my French on which I see as the brimming tension-surface of alcohol in a small glass. Passing on to the blue group, there is steely x, thundercloud z, and huckleberry k. Since a subtle interaction exists between sound and shape, I see q as browner than k, while s is not the light blue of c, but a curious mixture of azure and mother-of-pearl. Adjacent tints do not merge, and diphthongs do not have special colors of their own, unless represented by a single character in some other language (thus the fluffy-gray, three-stemmed Russian letter that stands for sh [S], a letter as old as the rushes of the Nile, influences its English representation). In the green group, there are alder-leaf f, the unripe apple of p, and pistachio t. The word for rainbow, a primary, but decidedly muddy, rainbow, is in my private language the hardly pronounceable: kzspygv. As for other famous synesthetes, there is the artist David Hockney (see Cytowic, 2002). In general, this does not show up in his painting or photography artwork too much. However, it is a common underlying principle in his construction of stage sets for various ballets and operas, where he bases the background colors and lighting upon his own seen colors while listening to the music of the theater piece he is working on. Richard Feynman (1918-1988), winner of the 1965 Nobel Prize in Physics, was a synesthete. There are strong indications and good reasons for believing that the Serbian-born American physicist and inventor NikolaTesla (1856-1943) was also a synesthete (see. These types of "heroes" can play essential roles both for young synesthetes and for their non-synesthete parents. Most normal perceivers have multiple senses within each of the traditional senses anyway. What we call touch might actually be broken down into at least five different senses (consider, for example, the difference between feeling a tickle on your arm and a sensation inside your stomach). Also, pain could probably be broken down into at least two if not three or more separate senses. And temperature could be broken down into two separate components-heat detection is separate from cold detection. And then there is also proprioception, balance, vomeronasal perception of pheromones, and others. That is, for example, whereas a normal perceiver cannot see into the ultraviolet spectrum, neither can a synesthete. Whereas a normal person cannot hear ultra-high frequencies that a bat hears, neither can a synesthete. Similarly, Ramachandran and Blakeslee (1998) report that amputees with phantom limbs tend to eventually start operating with two simultaneous realities, "the phantom limb does exist and is still there," and "the limb does not exist and is not there. Humans take for granted that what each of us sees, hears, tastes, smells, and otherwise perceives is very much like that of the next person. Especially at a sensory level, most of us believe that our realities are pretty much the same. It might, however, be of interest to normal perceivers to hear that the quite larger majority of "colored-music" synesthetes I have corresponded with over the years were firmly convinced that everybody perceived music as colored; most of them were not shaken from this belief until well over the age of 20. I personally do not feel that my own synesthesia is some kind of gift from someone or something. I am not somehow mystically blessed in that I somehow see a hidden truth that others do not. I believe I perceive music and flavors differently because my brain is sending signals to places different and/or in a different fashion than how it does in the average brain. To say that I "take in so much more of the world than normal people do" (to paraphrase a claim regarding synesthetes frequently expounded upon on the Synesthesia List and elsewhere) would imply that there is something actually out there to take in that others are not getting. Rather, odd wiring and/or neuronal feedback is creating something in here-inside my head. It may be perceptually real in one way, but it is not real (and I know very well it is not real) in another, more generally applicable, way. Nevertheless, for the past few months, I have been dealing (fairly unsuccessfully) with trying to burst the bubbles of more than one non-synesthete colleague who seem quite seriously convinced that I have some form of mystic, spiritual connection to alternate dimensions or astral realms. From about October 2002 through February 2003,1 served as a consultant to a commercial chemical laboratory which makes food additives, training and working as a taste-tester and "nose. During the course of various experiments and conversations, I have been asked, "Can you do this for us Despite my presenting team members with scientific journal articles regarding synesthesia (such as those by Ramachandran and Hubbard), after 5 months, I am still basically considered by them as having "special insight" into "hidden truths" and that my "gift" is not via a neurological difference but from having a "more developed connection" with. Nor is it by any means a trivial concern: For example, recently, on an unmonitored synesthesia discussion chat-room web page, I noted one person who declared herself to be a synesthete explaining to another (self-declared) synesthete, who had come hoping for expert advice from trained medical professionals, how his touch-sound synesthesia perceptions were based upon "lines" and "vibrations" as per Californian variations on concepts of Buddhism, mysticism, and chakras. During the last year that I lived in Taiwan (2000-2001), I was interviewed by an associated group of television stations and newspapers for an evening news and newspaper feature regarding my synesthesia. When the features came out (all in Chinese), they were titled with a Chinese phrase which may be generally translated as "super-powers"; the same phrase is used in describing mythological demons, demigods, and cartoon and comic book superheroes. Rather than being informative pieces about a rare neurological condition, the features became an embarrassing joke that I then had to deal with for the next month. Many subscribers to the Synesthesia List, for example, have come to me after having waded through numerous web sites providing gross misinformation and unfounded conclusions regarding synesthesia; these people are often extremely confused, but they also come holding incorrect assumptions, which it is then very difficult to dissuade them from. Pseudoscience, mysticism and such are not mere trivial concerns here; the spreading of misinformation, and lack of concern about the spread of misinformation, can directly hurt and impede synesthetes, just like it can hurt epileptics, autistic people, homosexuals, or others. As I write this paragraph, my most recent request for consultation on a project came from a person who hoped to find and employ synesthetes to help him detect ghosts. After all of the horror stories I have mentioned about misdiagnosis, ridicule, scorn, and bad science, do I have anything positive to say regarding any doctors, psychiatrists, and other types of researchers There have been many who have definitely advanced our knowledge of synesthesia and thus lent a helping hand. Baron-Cohen, Wyke, and Binnie (1987) established a set of tests that are now deemed to show that synesthesia is a real phenomenon, based upon its consistency; variants of this test are used to determine whether subjects may be shown to have certain forms of synesthesia before then proceeding to further experiments. In 1989, Cytowic produced his volume on synesthesia, reintroducing the topic to the neuroscience and medical community. He followed through in 1993 with a "pop reader" book on synesthesia which went on to gain international attention, including bestseller status, and was translated into additional languages. In 1995, Paulesu and his colleagues (1995) (which included Baron-Cohen) did positron emission tomography scan studies of colored-word synesthetes, revealing that there were sections of the brains of synesthetes that "lit up" differently than those of non-synesthetes performing the same word-recognition tasks, indicating that there were, indeed, neurological differences between synesthete and non-synesthete brains. Such studies have now been followed up using functional magnetic resonance imaging, magnetoencephalography, and event related potential technologies; Paulesu et al. Duffy, a synesthete, has produced a volume that is a combination of autobiography, biography of other synesthetes, and general reader information regarding synesthesia (2001); this book has gone into paperback editions and is gaining widespread recognition, leading many to seek additional information regarding synesthesia. In separate, simultaneous studies, Mattingly, Rich, Yelland, and Bradshaw (2001) in Melbourne, Australia, Ramachandran and Hubbard (2001a, 2001b) in La Jolla, California, and Smilek, Dixon, Cudahy, andMerikle (2001a, 2001b, 2002) at Waterloo, Ontario, Canada, developed sets of tests to show conclusively that colored-grapheme synesthesia is a perceptual phenomenon, not a visual aberration, and, once again, to show that synesthetes could not possibly be making it up. And we now have these researchers and others joining together each year to share their work with each other and with synesthete and non-synesthete audience members at conventions such as those held by the American Synesthesia Association. Revealing Synesthesia On May 19, 2000, the first annual meeting of the American Synesthesia Association was held at Princeton University. Perhaps not surprisingly, one of the things that most attendees mentioned was the coffee breaks between the paper and presentation sessions. Virtually every message I received, from synesthete and non-synesthete alike, mentioned how the synesthetes around the coffee and cookies were happily proclaiming, "Finally, I feel justified! After all these years, I finally feel like my way of seeing the world is just as good-is also real! My mother clipped an article from the Washington Jewish Week about perfect pitch for me (I also have perfect pitch) and the article mentioned that an even smaller subset of people are "synesthetes" and see colors for every musical tone. For me, what I now know to be synesthesia is not just a cute or freakish "talent," it is the manner in which I organize my thoughts and understand the world around me. However, lack of knowledge about synesthesia-within the medical and scientific community, and, more broadly, among the general public-is considered a major problem by the synesthete community. Rather, we need and want non-synesthete experts, family members, and concerned others to be informed about the occurrence and nature of our experiences so that it stops being thought of as an aberration, but rather as a normal variant of perception. Together, we all need to work at finding ways to get rid of biases, misconceptions, pseudoscientific misinformation, dogmatism, and intolerance, so that far many more synesthetes can finally feel a sense of relief and acceptance. And that is why I sincerely applaud the other contributors to this book: You are of the small, but I hope growing, crowd of people who are making an extremely significant difference! An investigation of the cognitive and perceptual dynamics of a color-digit synaesthete. Digit-colour synaesthesia: An investigation of extraordinary conscious experiences. Tyler ynesthesia is often associated with a limited subset of sensory associations, particularly colors with music, colors with numbers, and sounds with shapes. But as a concept it embraces any cross-sensory association and even cross-modality association within specific senses, such as color with shape, for example. Indeed, the commonly reported association between color and number is itself an association between a sensory attribute and the conceptual attribute of number, which is not associated with any specific sense. For this article, I was asked to offer comments about synesthesia from a personal perspective, since I experience a limited degree of synesthesia.

The underlying demyelinating process is demonstrated by electrophysiological and asthma definition gina generic 100 mcg ventolin, if needed asthma phenotypes definition discount ventolin 100 mcg buy on-line, by pathological studies asthma symptoms 7dp3dt purchase ventolin overnight. Yet asthmatic bronchitis yogurt order generic ventolin, normal protein content is possible (found in up to 50% of patients asthma treatment videos buy ventolin 100 mcg low cost, in some series) (11). Almost 80% of reported patients present their first symptoms between 20 and 50 years of age (1). Guillain-Barre and Other Immune-Mediated Neuropathies 431 therapies suggest that the disease is immune mediated, even if the precise mechanism and the target antigens of this immune response are still unknown. Most patients have clinical features of mononeuropathy multiplex, with a subacute, progressive, generalized but asymmetric, painful, sensorimotor neuropathy (18). Nerve biopsy is necessary to establish the diagnosis in most cases, particularly in patients with ``nonsystemic' vasculitic neuropathy (18). In those with ``nonsystemic' disease, cyclophosphamide should also be used if prednisone monotherapy is ineffective or the patient relapses with tapering (18). Paraneoplastic Neuropathies Vasculitic Neuropathies Peripheral neuropathy is a well-recognized consequence of systemic vasculitis, caused by vasculitic involvement of vasa nervorum resulting in nerve ischemia and Wallerian degeneration (18). In some cases (up to one third) of biopsy-proven vasculitic neuropathy, constitutional symptoms are absent and no underlying systemic disease can be detected (8), hence the name ``nonsystemic' vasculitic neuropathy. However, clinically silent involvement of other organs is likely, and muscle biopsy often reveals vasculitic changes indicating that the underlying pathology is not confined to peripheral nerve (8). Paraneoplastic neuropathies are a heterogeneous group of autoimmune disorders, occuring in patients with cancer, most commonly small cell lung cancer, without a direct effect of the tumor mass or its metastases on the nervous system. Paraneoplastic sensory neuronopathies are the most frequent, but there is often motor, autonomic, or central nervous system involvement as well. Therapy is directed at treating the cancer as well as suppressing the immune system response, but it is generally unsatisfactory. Diagnosis Recognition of vasculitis as the cause of peripheral neuropathy is important since the disorder is treatable. Systemic vasculitis should always be considered when mononeuropathy multiplex occurs in conjunction with constitutional symptoms, such as fever, anorexia, weight loss, malaise, and nonspecific pains. The diagnosis is straightforward in cases of known systemic vasculitis, but should also be considered in patients who otherwise seem healthy, since 432 8. Levy Y, Uziel Y, Zandman-Goddard G, Rotmen P, Amital H, Sherer Y, Langevitz P, Goldman B, Shoenfeld Y. Though it was lumped with multiple sclerosis for many years it is now a clearly defined disease entity by clinical, imaging and laboratory criteria. The main laboratory markers are high levels of antibodies to aquaporin 4 which is localized in the most affected areas. This disease may be the first of many to be separated out of the group of multiple sclerosis syndromes. Keywords Neuromyelitis optica Á Devic syndrome Á aquaporin 4 Á multiple sclerosis pathological pictures (3) each representing probably many separate disease entities. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ``McDonald Criteria'. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. Myelitis is an anatomically defined autoimmune reaction occurring in the spinal cord. There are many causes of myelitis including an autoimmune reaction associated with viral infections, systemic autoimmune diseases such as systemic lupus erythematosus and sarcoid. Immunopathogenic mechanisms incorporate leukocyte­endothelial interactions, immune complex injury, autoantibody damage, impairment of vascular tone, and alterations in coagulation. Because of the morbidity and mortality associated with the disease, and the potential utilization of immunosuppressive agents as the modality of therapy that harbor potential serious adverse events, it is imperative to assure a proper diagnosis (1, 2). In this chapter, we discuss the clinical and pathological manifestations of the different entities and the diagnostic criteria for this novel classification. The classic presentation is progressive and cumulative with multifocal neurologic dysfunction. Headache and confusion are the most common presenting symptoms and the most common finding is hemiparesis. Ataxia of the limbs or gait and focal cortical dysfunction, including aphasia and seizures are also reported. Occasionally, patients present with multiple sclerosis-like disease or disease restricted to one portion of the nervous system. Perhaps, Type I vasculitis is a spectrum of disorders, which would explain the variability in clinical presentation and even response to therapy (3). Focal manifestations are more common in patients with secondary antiphospholipid syndrome (6). The vascular inflammation is usually of a chronic granulomatous nature, with monocytes, histiocytes, lymphocytes, and plasma cells invading the walls of small arteries and veins, particularly in the leptomeninges. Some of the infectious agents are associated with systemic vasculitis (hepatitis viruses); they may induce focal or diffuse neurological manifestations even in the absence of clinical systemic disease. The description of the various systemic vasculitides is beyond the scope of this chapter. The histopathology in these patients includes granulomatous, necrotizing, or eosinophilic vasculitis. Recognition of the neurological entities and excluding other diseases is of utmost importance because therapy will differ. Absolute proof by tissue diagnosis is a prerequisite and without it empiric immunosuppressive therapy should not be instituted (3, 4, 5). The lesions are commonly bilateral and supratentorial; there may be involvement of the veins. Single or multiple areas of segmental narrowings and dilatations of the vessel, vascular occlusions, hazy vessel margins, and collateral formation. Segmental inflammation of small arteries and arterioles, intimal proliferation and fibrosis, with sparing of the media. A mild lymphocytic pleocytosis and slightly elevated protein levels are most commonly detected, again being nonspecific. Furthermore, oligoclonal bands with an elevated IgG index, low glucose levels, and elevated leukocyte counts of several hundreds have all been reported. Angiography the typical findings in cerebral angiography are single or multiple areas of segmental narrowings and dilatations along the course of the vessel, vascular occlusions, hazy vessel margins, and collateral formation. The utilization of serial angiographies as follow-up in these patients is not established. The value of angiography is also not specific enough, and normal angiography results have been reported in many cases (3). Lesions suggestive of ischemia and inflammation will involve the cortex and white matter, some within known arterial territories. The lesions are commonly bilateral and supratentorial but have been described in the brainstem and cerebellar regions. Electroencephalogram and brain computerized tomography are abnormal, nonspecific, and hence not recommended. In addition, biopsy that includes the leptomeninges, cortex, and subcortical tissue enhances the sensitivity of the diagnostic test. False-positive findings are rare, but it is to be emphasized that the biopsy should be performed in the appropriate clinical, laboratory, and neuroimaging setting. If a lesion is not visible, then a blinded biopsy from the non-dominant frontal or temporal pole including the leptomeninges is recommended (5). The typical biopsy specimen reveals segmental inflammation of small arteries and arterioles, intimal proliferation, and fibrosis, with sparing of the media, and in some cases multinucleate giant Langerhans cells (12). Diagnostic Criteria Diagnostic criteria have been established by Calabrese in 1986 (13) and 1997 (3). These criteria are based on the assessment of less than 200 patients that were reviewed in the literature over 20 years. The limitation to evaluation of the beneficial potential of this modality of treatment is the rarity of disease, and possibly the difficulty of diagnosis. Upon establishing the underlying disease, appropriate therapy should be instituted for the systemic disorder. Intravenous immunoglobulin therapy has been beneficial in a few cases of patients with neuropsychiatric lupus (15). Diagnostic Caveats the utilization and interpretation of any one test whether it is physical exam, a blood test, neuroimaging, or tissue sampling are influenced by many factors and include the pre-test probability (11). Irani and Bethan Lang Abstract Epilepsy is one of the most common neurological disorders; however, an underlying aetiology remains undetermined in the majority of cases. There is growing evidence of an autoimmune basis for a subset of epilepsies, and a number of antibodies have now been detected in the sera of patients with epilepsy. Many of these antibodies may not be pathogenic; however, those directed at ion channels or cell-surface receptors would be candidates in the direct causation of the disease. An example of such an antibody is the anti-voltage-gated potassium channel antibody. Other antibodies, such as those directed against glutamic acid decarboxylase, and neuronal gangliosides have a more uncertain role in aetiology but have been measured in many epileptics. Keywords Epilepsy Á antibody Á autoimmunity Á voltage-gated potassium channel Á glutamic acid decarboxylase Introduction Epilepsy affects around 0. Epilepsy can affect patients of all ages, with many cases proving significant therapeutic challenges. Although the clinical diagnosis of seizure episodes has been refined over many years, only the minority of patients can be given a specific underlying diagnosis to enable targeted treatment approaches. Such diagnoses are often based upon imaging technology, which allow the detection of underlying structural lesions such as vascular, malignant, traumatic and developmental insults. In addition, some of the remaining epilepsies are believed to have an underlying genetic aetiology. Such specific genes include those encoding potassium channels (benign familial neonatal convulsions) and nicotinic acetylcholine receptors (autosomal dominant nocturnal epilepsy). It is feasible to suggest that autoantibodies bind to and modulate the function of these and other ion channels, with a clinical phenotype similar to those produced by the genetic mutations. Hence, ion channels and surface receptors are now being implicated in the aetiology of autoimmune epilepsy. Additionally, controversies in the systems used to classify the epilepsies may also account for some of the confusion encountered. Classification systems include those which are semiology based, dealing with the phenotype of seizures, or localisation-based, describing the cerebral anatomical origin of the seizure. In addition, some authors have suggested a treatment response classification for pragmatic management reasons. Utilisation of appropriate classification systems may allow for more accurate laboratory-based investigation of epilepsy and encourage some phenotype­antibody correlations to emerge. Autoantibody binding to these Kv1 channels could cause channel dysfunction by pharmacological antagonism or by inducing channel down regulation. The lack of functional channels may result in prolonged depolarisation and neuronal hyperexcitability. However, no such pathogenicity has yet been demonstrated with sera from patients with epilepsy. The results are usually reported in picomoles of I125-toxin binding sites per litre of serum (pM). Patients with higher titres were more commonly found to have a subacute, encephalopathic illness associated with their presentation, whilst those with lower titres tended to have less cognitive involvement (4). The majority of these patients improve dramatically when promptly treated with corticosteroids. Despite these limitations, there are data suggestive of direct antibody pathogenicity. One early article described acute onset of drug refractory temporal lobe epilepsy in a young man. His seizures, refractory to multiple antiepileptic drugs, were eventually treated successfully with steroid therapy (11). However, other groups were unable to confirm these findings using native protein expression techniques (7). However, the pathogenic significance of such antibodies has not been fully investigated. Others Autoantibodies Antiphospholipid antibodies have been described at higher frequencies in epileptic populations, as have antibodies associated with coeliac disease, prompting successful treatment with a gluten-free diet (17). Treatment and Prognosis At the present time, only a few patients with pure autoimmune epilepsy have been treated with immunosuppressive therapies. As many of the antiepileptic ``drug-resistant' epileptics are a particularly difficult group to manage, the novel use of immunosuppression in this population may impact favourably upon their prognosis. Many such antibodies are directed against plausible epileptogenic targets including ion channels, such as voltage-gated potassium channels, and receptors, for example glutamate receptors. The differential diagnosis of chorea is wide and finding the specific cause can be a challenging task. This chapter reviews the autoimmune causes of chorea, defining diagnostic criteria based on clinical presentation and serological markers. It is important to appreciate the difference between chorea and myoclonus, which present as a faster involuntary movement, involving single or several muscles or part of a single muscle.

ventolin 100 mcg purchase overnight delivery

Similarly asthma treatment stages cheap 100 mcg ventolin fast delivery, a lifetime history of an anxiety disorder was associated with poorer outcomes in surgical populations asthma treatment 4 syphilis generic ventolin 100 mcg on-line. Given the prevalence of anxiety in obese populations and its potential impact asthma handouts buy ventolin with paypal, continued monitoring and possible treatment are recommended in obese populations asthma with status asthmaticus order ventolin 100 mcg with mastercard. Binge eating episodes are associated with at least three of the following associated symptoms: eating past the point of fullness asthma definition unity discount 100 mcg ventolin amex. Diagnostic criteria are met when binge episodes occur one time per week for a period of 3 months [10]. Previously, such symptoms were considered an eating disorder not otherwise specified with suggested diagnosis when binge episodes occurred a minimum of two times per week for a period of 6 months [10]. Additionally, binge eating is differentiated from night eating and graze eating disorders. Night eating episodes are associated with three of the following symptoms: no desire to eat in the morning and/or skipping breakfast four or more mornings per week, a strong urge to eat after dinner and/or during the night, sleep onset and/or sleep maintenance insomnia four or more times per week, perception of needing to eat to fall asleep, or worsening mood in the evening hours. A less researched maladaptive eating pattern is graze eating described as continuously snacking throughout the day often resulting in an irregular meal pattern and increased caloric intake, and is associated with a sense of loss of control over eating [25]. Specifically, the majority of the literature indicates a lack of relationship between presurgical binge eating and weight loss outcomes, with only some studies indicating a negative or positive impact on 48 J. However, postoperative loss of control eating has been associated with poorer weight loss and psychological functioning. Despite a lack of association found between preoperative binge eating and postoperative weight loss, preoperative eating disorder treatment has been shown efficacious. Substance abuse is defined as the recurrent use of a substance despite a negative and recurrent impact on social or occupational functioning, recurrent interaction with the legal system, and continuing to use in situations in which it is physically hazardous [10]. Substance dependence is defined when a minimum of three of the following associated symptoms are met: tolerance. The lifetime prevalence rate for any substance use disorder in the general population is 15. Interestingly, the lifetime prevalence rate for any substance use disorder is significantly higher amongst obese patients seeking weight loss surgery (35. However, current rates of substance use disorder are lower than the population amongst obese patients seeking weight loss surgery [46, 65] (1 % compared to 8. The prevalence of current alcohol abuse or dependence is less than 1 % in preoperative bariatric patients [60, 85]; however, a study examining alcohol use disorders based on a measure rather than clinical interview reported a prevalence rate of 7. It is unclear why current rates of abuse or dependence are lower in weight loss surgery populations; however, perhaps they are related to presurgical intervention or education as active alcohol and/or substance abuse or dependence is a contraindication for weight loss surgery [79]. Recent literature has examined increased rates of alcohol use disorders after weight loss surgery. Another study found that amongst patients who had gastric bypass surgery within the past 2 years and who had reported an alcohol use disorder preoperatively in remission (83. Additionally, a study examined substance abuse treatment admissions and found that 2­6 % of admissions consisted of patients who had previously had weight loss surgery [106]. However, the rate of hazardous drinking increased significantly between the first and second year after gastric bypass surgery [66]. Risk factors identified include male gender, younger age, smoking, recreational drug use, regular consumption of alcohol prior to surgery, lower sense of belonging, and worse postoperative mental health and treatment [66]. Interestingly, these findings are not replicated amongst patients who underwent alternate surgical procedures. Despite literature indicating that gastric bypass patients are a particularly vulnerable population for concerns regarding alcohol use, a few studies have demonstrated improved weight loss outcomes in patients with a history of substance abuse in remission [20, 48]. In particular, these studies found that patients with substance abuse in remission had better weight loss outcomes than patients without this history [20, 48]. The authors suggest that this history and subsequent remission of symptoms resulted in an increased ability to make major lifestyle changes similar to those required by weight loss surgery [20, 48]. The literature above indicating increased rates of lifetime substance use disorders [85] in obese patients emphasizes the importance of careful screening of substance use disorders, particularly screening for alcohol abuse in those seeking weight loss surgery [66]. Heinberg surgery candidates follow the screening guidelines from the National Institute on Alcohol Abuse and Alcoholism [50, 83] and include screening for at-risk or heavy drinking. E-Have you ever had a drink first thing in the morning to steady your nerves or to get rid of a hangover For additional information on assessing and treating alcohol use disorders, visit pubs. For additional information on assessing and treating alcohol in a weight loss surgery population read suggested recommendations by [50]. Psychosocial Consequences Stigma Persons with obesity are highly stigmatized and face prejudice and discrimination due to their weight. Although the majority of the population is overweight or obese, the prevalence of weight discrimination is comparable to rates of racial discrimination, especially among women [94]. In a review of the obesity stigma literature, [92] Puhl and Heuer (2009) noted empirical support for discrimination against the obese in a wide variety of domains including hiring, placement, and discharge prejudice in employment; wages and promotions; education; public accommodations. Puhl and Brownell (2006) [91] queried obese individuals about most common and frequent sources of stigmatization and found that family members were most frequent followed by doctors, classmates, coworkers, spouses, and employers/supervisors. Commonly held stereotypes include that obese individuals are: lazy, overeat, or binge; unintelligent, lack willpower, and have poor hygiene; and are unattractive/ugly [91]. Thus, obese individuals must endure, confront, and cope with these injustices largely on their own [92]. Stigmatization experiences have been associated with psychological distress as well as health behaviors. Weight bias may also mediate the relationship between obesity and self-esteem and poor body image that is often present in obese individuals [92]. When patients are queried regarding coping strategies for managing stigmatizing experiences, 80 % of women and 79 % of men endorsed eating. This was the second most utilized strategy after coping self-statements [91] suggesting that stigmatization may make obesity worse. Similarly, a survey of obese women found that those who had internalized negative weight-based stereotypes had more frequent binge eating behaviors [93]. These include more explicit attitudes that are held in conscious awareness as well as implicit attitudes which occur automatically and are outside of conscious awareness. Obese patients experiencing stigmatizing encounters in health care have been shown to delay or forgo a variety of preventative health-care services. Patients often report negative attitudes of their providers, disrespect, and embarrassment about weighing procedures, unsolicited advice about their weight, and lack of weight-appropriate equipment [10]. Like cultural sensitivity, health-care professionals can increase skills and their environment to make all patients more comfortable and welcome. Wadden and Didie (2003) queried obese men and women about what term they would like their physician to use when discussing their obesity. Interestingly, when queried about attitudes about terms "obese people" or "fat people," obese evoked stronger negative reactions in both genders [125]. To make patients of all sizes more comfortable, individuals should be weighed in a private setting, away from other patients and personnel. Further, weight should be recorded silently without commentary or negative body language. Finally, appropriate, wide-based scales that measure > 350 pounds are recommended for all health-care settings. More information on setting up an appropriate physical environment is offered by the Yale Rudd Center for Food Policy and Obesity. To combat bias and stigma, providers should strive to remember that: (1) obesity is a chronic disease that results from a complex interplay between biological, genetic, psychosocial, and environmental factors; (2) obese patients come in all shapes and sizes as well as personality profiles, physical and psychological strengths, and weaknesses; (3) there is benefit and merit in all human diversity including the diversity of size, shape, and weight; and (4) obese patients have the right to be treated as a unique individual. Impact on Outcome Quality of Life Health- and weight-related quality of life are negatively impacted by obesity [69]. Improvements in the quality of life related to postoperative phases of weight loss, weight regain, and weight maintenance with most improvements noted in the first year of weight loss [63]. Body Image Body image is an important aspect of the quality of life [105] and one of the most prevalent motivators for weight loss amongst weight loss surgery candidates [127]. Obese individuals seeking weight loss surgery have been shown to have higher body image dissatisfaction than normative samples even after weight loss [119]. Amongst 3 Psychosocial Morbidity and the Effect of Weight Loss 53 obese women, body image dissatisfaction is also associated with increased depressive symptoms, lower self-esteem, and a history of teasing [43, 78, 103]. Much of the literature indicates that body image improves with weight loss [1, 29, 36] and after weight loss via weight loss surgery [2, 53, 76, 84, 104, 105, 119, 122]. Additionally, reductions in body image dissatisfaction has been associated with increased weight loss [29, 105] and improved quality of life [105]. However, some literature indicates persistent negative body image after weight loss via weight loss surgery [52]. Improvements or lack thereof in body image may also be related to continual depressive symptoms rather than excess weight loss [77]. Additionally, persistent negative body image may be related to excess skin, continual overweight/ obese status despite weight loss, traits such as perfectionism or low self-esteem [119] [102], size estimations [108], or unrealistic weight loss expectations [49]. Conclusions/Future Directions Obesity is associated with significant psychiatric and psychosocial impairment including higher rates of depression, anxiety, substance abuse or dependence, as well as impaired quality of life, negative body image, and experiencing negative social stigma. Escalating rates of obesity amongst both adults and children emphasize the need to comprehensively assess and treat obesity and its comorbid medical and psychological conditions. Given the potential impact of and bidirectional relationship between obesity, mood, substance use disorders, eating disorders, and quality of life, all must be taken into account in determining an appropriate patient-centered treatment plan. The complexity of obesity points to the utilization of a multidisciplinary treatment team including medicine, psychology, nutrition, exercise physiology, and when appropriate surgery, when assessing and treating this condition. Future research should further examine the impact of obesity on psychological and psychosocial factors with sustained weight loss as well as duration of weight maintenance. Future research should also begin to explore preventative strategies for obesity and its medical and psychological comorbidities. Body image in obese patients before and after stable weight reductions following bariatric surgery. Depression is associated with increased severity of co-morbidities in bariatric surgical candidates. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Barriers to routine gynecological cancer screening for White and African-American obese women. Psychosocial evaluation of bariatric surgery candidates: a survey of present practices. Reliable change in depression during behavioral weight loss treatment among women with major depression. Psychosocial factors and 2-year outcome following bariatric surgery for weight loss. Eating related and general psychopathology in obese females with binge eating disorder. Comprehensive interview assessment of eating behavior 18­35 months after gastric bypass surgery for morbid obesity. Anxiety and depression in bariatric surgery patients: a prospective, follow-up study using structured clinical interviews. Quality of life after lab-band placement: influence of time, weight loss, and comorbidities. Body image: appearance orientation and evaluation in the severely obese: changes with weight loss. Sibutramine treatment in obesity: initial eating behavior in relation to weight loss results and changes in mood. Changes in symptoms of depression with weight loss: results of a randomized trial. Cognitive-behavioral therapy with simultaneous nutritional and physical activity education in obese patients with binge eating disorder. Weight stigmatization and ideological beliefs: relation to psychological functioning obese adults. Recent experiences of weight-based stigmatization in a weight loss surgery population: psychological and behavioral correlates. The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis. Binge eating and self-esteem predict body image dissatisfaction among obese men and women seeking bariatric surgery. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine. Characterization of the improvement in depressive symptoms following bariatric surgery. Discrepancy between ideal and realistic goal weights in three bariatric procedures: who is likely to be unrealistic Alcohol and bariatric surgery: review and suggested recommendations for assessment and management. A prospective study of body dissatisfaction and concerns in extremely obese gastric bypass patients: 6- and 12-month postoperative outcomes. The prevalence and correlates of eating disorders in the national comorbidity survey replication. Axis I psychopathology in bariatric surgery candidates with and without binge eating disorder: results of structured clinical interviews. Psychiatric disorders among bariatric surgery candidates: a relationship to obesity and functional health status. The descriptive epidemiology of commonly occurring mental disorders in the United States. Effects of sibutramine and orlistat on mood in obese and overweight participants: a randomized study. Health and healthrelated quality of life: differences between men and women who seek gastric bypass surgery. Two-year changes in healthrelated quality of life in gastric bypass patients compared with severely obese controls.

generic ventolin 100 mcg mastercard

Leukocytoclastic vasculitis predominantly involving the skin with occasional involvement of other organ systems may be the presenting sign of some neoplasms (1) asthma definition american thoracic society 100 mcg ventolin buy mastercard. In most cases asthma or bronchitis ventolin 100 mcg buy amex, surgical removal of tumor and/or appropriate therapy is associated with the disappearance of vasculitic lesions asthma zinc order on line ventolin. Hypersensitivity vasculitis and Henoch-Schonlein purpura: a comparison ¨ between the 2 disorders asthma control definition quality ventolin 100 mcg. Cytokine production by malignant cells may be one of the precipitating factors that lead to vasculitis (13) asthma treatment tamil cheap 100 mcg ventolin otc. Patients with leukocytoclastic angiitis which is confined exclusively to the skin are diagnosed as localized cutaneous vasculitis. The pattern of disease associations with localized cutaneous vasculitis includes underlying systemic illness like infection or malignancy and also connective tissue disease (14, 15, 16). Some patients may initially be diagnosed as having cutaneous leukocytoclastic angiitis but will subsequently be found to have systemic form of small-vessel vasculitis. Hypersensitivity reactions commonly cause rash also, which may be presented as urticarial lesions. If urticarial lesions persist for at least 24 hours and sometimes leave traces of hyperpigmentation, urticarial vasculitis should be considered. The lesions of urticarial vasculitis are often accompanied by stinging or burning and not by pruritus as in common urticaria. Most patients with urticarial vasculitis have the hypocomplementemic subtypes (17) and are likely to manifest signs of an underlying systemic autoimmune disease. Although rheumatoid factor is present in most patients, the inciting antigen is still undefined. Many of the side-effects of glucocorticoid therapy are marked by decrease in frequency and severity in patients on alternate-day regimens compared to daily regimens. Colchicine, hydroxychloroquine, or dapsone may also be tried for persistent disease. As in every other disease, it should be remembered that each patient requires individual decision-making and should be practiced in order to provide maximal therapeutic efficacy with minimal toxic side-effects. The differentiation between the vascular lesions of periarteritis modosa and hypersensitivity. The type, intensity, and duration of therapy are based on the degree of disease severity in an individual patient. When there is an involvement of organs and tissues except skin or synovial membranes, glucocorticoids should be instituted immediately. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. In contrast to dermatomyositis, neoplastic-associated cases do exist but in a lesser proportion. In most cases, a satisfactory clinical response can be obtained with corticosteroids and immunosuppressive agents, but a fatal evolution may occur in a small percentage of cases. Expression of cytokines has been demonstrated in mononuclear cells in affected muscles and may contribute to local inflammatory response and to perpetuation of the autoimmune response. Therefore, better knowledge of the immune mechanisms will allow identification of new potential therapeutic targets (6). It is defined as a subacute myopathy that basically affects adults and presents with weakness of the proximal muscles. Patients report difficulty with everyday tasks such as climbing steps, rising from a seat, or lifting objects. Cardiac manifestations include myocarditis, arrhythmias or congestive cardiac failure. Rash (characteristic of dermatomyositis) Family history of neuromuscular diseases Exposure to myotoxic drugs, especially penicillamine, zidovudine, and (rarely) statins Endocrine disease (hypothyroidism, hyperthyroidism, hypoparathyroidism, hypercortisolism) Neurogenic disease (exclude by electromyography and neurological examination) Dystrophiesa and metabolic myopathies (excluded by history and muscle biopsy) Inclusion body myositis (excluded by clinical examination and muscle biopsy) a Espi´ gol and Grau Electromyography shows a myopathic process with increased spontaneous activity with fibrillations, complex repetitive discharges and positive sharp waves (7). An open biopsy provides a larger tissue sample that allows not only conventional microscopic examination but also immunohistochemical studies and electron microscopy. Dysferlin deficiency and facioscapulohumeral muscular dystrophies in particular because severe inflammation can be found in muscle biopsies. These manifestations may sometimes occur in hypertensive patients because of long-term steroid treatment. Arthralgias may occur even without an association with connective tissue diseases. Interstitial lung disease is more common in patients with anti-Jo-1 or other antisynthetase antibodies (9). Screening with a complete physical examination and complementary tests (according to age and personal history) should be made yearly (6,11). All myopathies have a lot of manifestations in common and could be difficult to separate them. Second line agents such as immunosuppressives or intravenous immunoglobulin should be considered when the disease is not controlled with corticosteroids (relapses, ineffectiveness of 3 months of high-dose prednisone and rapidly progressive disease). New therapies directed to cytokine modulation and the use of monoclonal antibodies are promising (6,7,15). Treatment Few controlled trials have been published and most of the experience with the use of drugs has arisen from case reports. Corticosteroids are the main initial treatment for inflammatory myositis, although their efficacy has not been established in randomized studies. The cause of the gradient is unknown and both genetic and environmental factors may be involved. Periorbital violaceous (heliotrope) erythema with or without associated edema of the eyelids and periorbital tissue. Symmetrical macular violaceous erythema overlying the dorsal aspect of the hands and fingers (where it can track the extensor tendon sheaths), extensor aspects of the arms and forearms, deltoids, posterior shoulders and neck (the shawl sign), V-area of anterior neck and upper chest, central aspect of the face and forehead. The main symptoms are weakness, affecting mainly the proximal muscles, and myalgias. The extensor muscles of the neck may be involved, causing difficulty in holding up the head (head drop). In severe cases, the respiratory and oropharyngeal muscles are involved causing dysphagia and respiratory difficulties. In some cases, a lack of coordination of the swallowing muscles occurs which may lead to ab ingestis pneumonia. Myalgias are less frequent than muscular weakness, and, when present, accompany the weakness. The most common clinical signs are reduction of the muscular strength in the proximal muscles, contractures and, late in the course of the disease, muscular atrophy (40% of cases). Skin manifestations sometimes accompany, but more often precede by several months or years the signs of muscle involvement (1, 3, 4, 5). Patients with inflammatory myopathies have a higher risk of malignancy than the normal population. Laboratory Abnormalities High serum levels of muscular enzymes are characteristic of the disease (5). Myoglobin is a protein present in skeletal and cardiac muscle, but not in other tissues, whose blood concentration can rise during muscular diseases, and can also be present in the urine. Late in the course of the disease, insertional activity may be decreased as a consequence of fibrosis. These abnormalities may be observed in 70­90% of patients; however, they are not specific because they can be detected in other muscular diseases. Generally, the biopsy is performed in the proximal muscles of the legs, choosing areas with active muscle involvement. The characteristic histological findings were reported earlier under the section Pathological Features. Anti-Mi-2 antibodies are directed against a nuclear protein of 7 subunits, which is part of a protein complex involved in gene transcription (11). Skin manifestations are recognized by physical examination and they do not usually require histological confirmation. Inflammatory myopathy is suspected on the basis of clinical features and confirmed by laboratory tests, including high serum muscle enzyme concentration, electromyography and muscle biopsy abnormalities. It is worthy to note that these criteria incorporate exclusion of other diagnosis. Because the advances in muscle immunopathology now let us to discriminate among the different inflammatory myopathies, Dalakas and Hohfeld have recently proposed muscle biopsy­based diagnostic criteria (4). Exclusion criteria: central or peripheral neurologic diseases, muscular dystrophies, granulomatous and infectious myositis, metabolic and endocrine myopathies, and myastenia gravis. Perifascicular, perimysial or perivascular infiltrates; perifascicular atrophy Present Not detected particularly dystrophies. This classification was also criticized because of a low sensitivity of some items leading to non-diagnostic muscle biopsy in some patients with myositis. Early diagnosis and treatment are crucial for avoiding atrophic changes of the muscle with consequent loss of function. Mortality is mostly related to cardiopulmonary disease, malignancies, and infections. Factors predictive of a bad prognosis are old age at onset, myositis severity, dysphagia, cardiac and pulmonary involvement, poor response to therapy, and the presence of malignancy (3). Starting therapy consists of prednisone 1­2 mg/Kg orally for 2­4 weeks, and then it should be gradually tapered to the lowest effective dosage. In some cases, cyclosporine A (3­4 mg/kg/day) has also been reported to be efficacious alone or in association with other immunosuppressants. Moreover, cutaneous manifestations may be controlled by the application of topical corticosteroids or the more recent class of calcineurin inhibitors, such as tacrolimus and pimecrolimus (3). Allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. If more extensive muscle testing is carried out, the results should be within normal limits (if such results are positive/abnormal, the patient can be classified as having ``hypomyopathic dermatomyositis' [see below]). Treatment with systemic immunosuppressive therapy for two consecutive months or longer within the first six months after skin disease onset (such therapy could prevent the development of clinically significant myositis). This designation was coined to emphasize the fact that the predominant clinical problem is skin disease in patients so affected. A working designation for those individuals in whom the onset of clinically significant muscle disease. However, to date there has been no formal effort to test and validate this approach. This definition was subsequently criticized by others on the basis that had more extensive muscle testing been carried out in such patients not exhibiting weakness. Secondary or associated cutaneous findings such as scale, pigmentary change, telangiectasia and/or edema can also be present. When fully formed, these papules become slightly depressed at the center which can assume a white, lacy appearance. Associated scale/ hyperkeratosis, pigmentary change, and/or telangiectasia may be present. Local therapy should begin with topical corticosteroids and topical antipruritics. Solution, spray, or foam-based corticosteroid preparations are best for pruritic scalp involvement while creams, ointments, and gels are best for other areas of the body. Nonsteroidal topical immunomodulators such as tacrolimus ointment and pimecrolimus cream can be used in steroid-sensitive areas such as the periocular tissue, face, and intertriginous areas. Systemic corticosteroids when indicated for systemic disease activity such as myositis or interstitial lung disease can be of benefit for the cutaneous inflammation. Other agents that can be of benefit include single-agent or combination therapy with the aminoquinoline antimalarials (hydroxychloroquine, chloroquine, quinacrine). Such patients might require traditional systemic immunomodulatory therapy with agents such as high-dose intravenous immunoglobulin, methotrexate, azathioprine, and/or mycophenolate mofetil. Clinically Amyopathic Dermatomyositis 163 sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis. Autoantibodies to 155 kD and Se autoantigens in patients with clinicallyamyopathic dermatomyositis. Would a new name hasten the acceptance of clinically-amyopathic dermatomyositis (dermatomyositis 10. Its prevalence varies among ethnic groups, but it is estimated at 35 per one million people over 50 years. Genetic as well as environmental factors and autoimmune processes might both have a role in its pathogenesis. It has a distinctive pattern of muscle involvement and different forms of clinical presentation. Diagnosis is suspected on clinical grounds and is established by a typical muscle pathology. Keywords Inclusion body Á myositis Á myopathy Á inflammation by the presence of vacuoles containing cytoplasmic degradation products with fibrillary nuclear and cytoplasmic inclusions. They suggest that these enzymes participate in the formation of insoluble amyloid deposits and may thereby contribute to progressive and debilitating muscle disease. This association is present in nearly 75% of the cases, but this figure may vary in different ethnic groups (2, 5, 6). A number of discrepancies suggest that these numbers underestimate the true prevalence of this myopathy. Heat drop and camptocormia (selective atrophy and weakness of paraspinal muscles) may occur, even as a form of clinical presentation.

Discount ventolin 100 mcg online. Asthma attack and ICU //OhSoZoey//.

References

  • Jay GD, Onuma K, Davis R, et al: Analysis of physician ability in the measurement of pulsus paradoxus by sphygmomanometry. Chest 118: 348-352, 2000.
  • Utley D, Lewin S, Cheng E, et al. Brain derived neurotrophic factor and collagen tubulization enhance functional recovery after peripheral nerve transection and repair. Arch Head Neck Surg 1996;122:407-413.
  • Spechler SJ, Goyal RK: The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 110:614, 1996.
  • Engel AG, Banker BQ. Ultrastructural changes in diseased muscle. In: Engel AG, Franzini-Armstrong C, eds. Myology. 3rd ed. New York, NY: McGraw-Hill; 2004:749-887.